Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2026-01-29 @ 1:29 PM
Study NCT ID:
NCT03906058
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2019-04-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
Sponsor:
Organization: